Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Armen Karapetyan"'
Autor:
Aleksandr Yengoyan, Tiruhi Gomktsyan, Vergush Pivazyan, Emma Ghazaryan, Roza Shainova, Armen Karapetyan, Diana Avetyan, Levon Aslanyan, Karine Baroyan, Alexander Tuzikov, Mariam Sargsyan, Bagrat Baghdasaryan, Nane Bayramyan, Sona Hakobyan, Arpine Poghosyan, Aida Avetisyan, Hranush Avagyan, Lina Hakobyan, Karalyan Zaven
Publikováno v:
Veterinary World, Vol 17, Iss 6, Pp 1281-1290 (2024)
Background and Aim: With the emergence of severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), antiviral drug development has gained increased significance due to the high incidence and potentially severe complications of the resulting
Externí odkaz:
https://doaj.org/article/a2bff0f6521c4e6ab4ed1aff973aa7b0
Autor:
Armen Karapetyan
Publikováno v:
History and Culture. Journal of Armenian Studies. 17:153-163
Հայաստան» օրաթերթը պատմական ասպարզ ելավ Զորավար Անդրանիկի անմիջական ջանքերով ու պատասխանատվությամբ: Զորավարը գտնում էր, որ արևելահայ պ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fed6e9d67b7ad9b1ebcae5975b3bd75
https://doi.org/10.46991/hc.2022.17.1.153
https://doi.org/10.46991/hc.2022.17.1.153
Autor:
Bishnu P. Joshi, Katharina Winkelbach, Armen Karapetyan, John C. Castle, Dennis J. Underwood, R.B. Stein, Marc Van Dijk, Volker Seibert, Chawaree Chaipan, Sandra Wimberger, Jun Seop Jeong
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology, Vol 10 (2019)
Adoptive T cell therapy using patient T cells redirected to recognize tumor-specific antigens by expressing genetically engineered high-affinity T-cell receptors (TCRs) has therapeutic potential for melanoma and other solid tumors. Clinical trials im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5ee8d19f37f6d63b46e2d304f5ddf50
http://europepmc.org/articles/PMC6817589
http://europepmc.org/articles/PMC6817589
Autor:
Daniel L. Levey, Mohamed Uduman, Antoine Tanne, Paisley T. Myers, Benjamin Morin, Jeffrey Raizer, Dennis J. Underwood, Shiwen Lin, Robert Stein, Mithun Khattar, Donald F. Hunt, Bishnu P. Joshi, Victor H. Engelhard, John C. Castle, Sandra Craig, Nicholas S. Wilson, Armen Karapetyan, Elise Drouin, Mark Findeis, Jennifer Buell, Erin D. Jeffery, John M. Goldberg, Amy Yang, Mark Cobbold
Publikováno v:
Cancer Research. 77:4609-4609
Most cancer cells carry mutations unique to the patient’s individual tumor and shared biochemical signatures that are not present in healthy cells. Agenus has three vaccine platforms designed to treat cancers based on the unique needs of a given pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f1db61bfbe24a97d166d6cc45282742
https://doi.org/10.1158/1538-7445.am2017-4609
https://doi.org/10.1158/1538-7445.am2017-4609
Autor:
Benjamin Morin, R.B. Stein, Armen Karapetyan, Bishnu P. Joshi, Mohamed Uduman, Daniel Levey, Jeffrey Raizer, Amy Yang, Nicholas S. Wilson, Antoine Tanne, Shiwen Shiwen, Elise Drouin, John C. Castle, Sandra Craig, Jennifer Buell, Mithun Khattar, John M. Goldberg, Justin Zelin, Mark Findeis
Publikováno v:
Cancer Immunology Research. 4:A037-A037
Agenus is clinically testing Prophage™, an individualized tumor vaccine which uses heat-shock proteins endogenously complexed to neo-antigens harvested from the patient's own tumor. Agenus' genomics and bioinformatics unit rapidly identifies potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a9da5b0effcec22ff16c81be5a21769
https://doi.org/10.1158/2326-6066.imm2016-a037
https://doi.org/10.1158/2326-6066.imm2016-a037